PDL BioPharma (PDLI) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts PDLI Hot Sheet
Price: $2.47 --0%
Financial Fact:
Interest and other expense: -4.51M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Interest and other expense: -4.51M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
PDL BioPharma (NASDAQ: PDLI) reported Q3 EPS of $0.08, in-line with the analyst estimate of $0.08. Revenue for the quarter came in at $53.6 million versus the consensus estimate of $50.69 million.
For earnings history and earnings-related data on PDL BioPharma (PDLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
- Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
